COVID-19 and abnormal uterine bleeding: potential associations and mechanisms
Open Access
- 19 February 2024
- journal article
- review article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 138 (4) , 153-171
Abstract
The impact of COVID-19 on menstruation has received a high level of public and media interest. Despite this, uncertainty exists about the advice that women and people who menstruate should receive in relation to the expected impact of SARS-CoV-2 infection, long COVID or COVID-19 vaccination on menstruation. Furthermore, the mechanisms leading to these reported menstrual changes are poorly understood. This review evaluates the published literature on COVID-19 and its impact on menstrual bleeding, discussing the strengths and limitations of these studies. We present evidence consistent with SARS-CoV-2 infection and long COVID having an association with changes in menstrual bleeding parameters and that the impact of COVID vaccination on menstruation appears less significant. An overview of menstrual physiology and known causes of abnormal uterine bleeding (AUB) is provided before discussing potential mechanisms which may underpin the menstrual disturbance reported with COVID-19, highlighting areas for future scientific study. Finally, consideration is given to the effect that menstruation may have on COVID-19, including the impact of the ovarian sex hormones on acute COVID-19 severity and susceptibility and reported variation in long COVID symptoms across the menstrual cycle. Understanding the current evidence and addressing gaps in our knowledge in this area are essential to inform public health policy, direct the treatment of menstrual disturbance and facilitate development of new therapies, which may reduce the severity of COVID-19 and improve quality of life for those experiencing long COVID.Keywords
Funding Information
- Royal Society of Edinburgh (1077)
- Medical Research Council (G1002033)
- Medical Research Council (MR/N022556/1)
- Medical Research Council (MR/W02697X/1)
- Wellbeing of Women (RTF1103)
- Wellcome Trust (209589/Z/17/Z)
This publication has 125 references indexed in Scilit:
- A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristicsAmerican Journal of Obstetrics and Gynecology, 2022
- SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT studyAmerican Journal of Obstetrics and Gynecology, 2021
- Direct or indirect endothelial damage? An unresolved questionEBioMedicine, 2021
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleedingCochrane Database of Systematic Reviews, 2019
- The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisionsInternational Journal of Gynecology & Obstetrics, 2018
- Excessive menstruation bleeding as a presentation of dengue hemorrhagic feverArchives of Gynecology and Obstetrics, 2012
- Endometrial haemostasis and menstruationReviews in Endocrine and Metabolic Disorders, 2012
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- EXPERIENCES WITH PROPHYLACTIC TYPHOID VACCINATIONArchives of internal medicine (1908), 1913